Home

setkat Politika porazit markers of diabetes compensation výstup čest arabština

IJMS | Free Full-Text | Insulin: The Friend and the Foe in the Development  of Type 2 Diabetes Mellitus
IJMS | Free Full-Text | Insulin: The Friend and the Foe in the Development of Type 2 Diabetes Mellitus

Targeting innate immune mediators in type 1 and type 2 diabetes | Nature  Reviews Immunology
Targeting innate immune mediators in type 1 and type 2 diabetes | Nature Reviews Immunology

IJMS | Free Full-Text | Metabolomic Biomarkers in Gestational Diabetes  Mellitus: A Review of the Evidence
IJMS | Free Full-Text | Metabolomic Biomarkers in Gestational Diabetes Mellitus: A Review of the Evidence

Endocrines | Free Full-Text | Diabetic Ketoacidosis Management: Updates and  Challenges for Specific Patient Population
Endocrines | Free Full-Text | Diabetic Ketoacidosis Management: Updates and Challenges for Specific Patient Population

Targeting inflammation in the treatment of type 2 diabetes: time to start |  Nature Reviews Drug Discovery
Targeting inflammation in the treatment of type 2 diabetes: time to start | Nature Reviews Drug Discovery

Pancreatic β-cell dysfunction in type 2 diabetes: Implications of  inflammation and oxidative stress
Pancreatic β-cell dysfunction in type 2 diabetes: Implications of inflammation and oxidative stress

Molecules | Free Full-Text | Potential Roles of Anti-Inflammatory  Plant-Derived Bioactive Compounds Targeting Inflammation in Microvascular  Complications of Diabetes
Molecules | Free Full-Text | Potential Roles of Anti-Inflammatory Plant-Derived Bioactive Compounds Targeting Inflammation in Microvascular Complications of Diabetes

Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report  by the American Diabetes Association (ADA) and the European Association for  the Study of Diabetes (EASD) | SpringerLink
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | SpringerLink

Frontiers | Biomarkers of autoimmunity and beta cell metabolism in type 1  diabetes
Frontiers | Biomarkers of autoimmunity and beta cell metabolism in type 1 diabetes

IJMS | Free Full-Text | Current Knowledge on the Pathophysiology of  Lean/Normal-Weight Type 2 Diabetes
IJMS | Free Full-Text | Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes

Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab  population | Nature Communications
Metabolic and proteomic signatures of type 2 diabetes subtypes in an Arab population | Nature Communications

Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell  Failure: Cell
Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure: Cell

The Beta Cell in Type 2 Diabetes | SpringerLink
The Beta Cell in Type 2 Diabetes | SpringerLink

Identification of potential markers for type 2 diabetes mellitus via  bioinformatics analysis
Identification of potential markers for type 2 diabetes mellitus via bioinformatics analysis

Endocrines | Free Full-Text | Diabetic Ketoacidosis Management: Updates and  Challenges for Specific Patient Population
Endocrines | Free Full-Text | Diabetic Ketoacidosis Management: Updates and Challenges for Specific Patient Population

Endocrine and Metabolic Insights from Pancreatic Surgery: Trends in  Endocrinology & Metabolism
Endocrine and Metabolic Insights from Pancreatic Surgery: Trends in Endocrinology & Metabolism

Frontiers | Diabetic cardiomyopathy: Clinical phenotype and practice
Frontiers | Diabetic cardiomyopathy: Clinical phenotype and practice

A Map of Human Type 1 Diabetes Progression by Imaging Mass Cytometry -  ScienceDirect
A Map of Human Type 1 Diabetes Progression by Imaging Mass Cytometry - ScienceDirect

Frontiers | Diabetes and Its Cardiovascular Complications: Comprehensive  Network and Systematic Analyses
Frontiers | Diabetes and Its Cardiovascular Complications: Comprehensive Network and Systematic Analyses

Cells | Free Full-Text | MicroRNA Signatures as Future Biomarkers for  Diagnosis of Diabetes States
Cells | Free Full-Text | MicroRNA Signatures as Future Biomarkers for Diagnosis of Diabetes States

PDF) Assessment of disturbed glucose metabolism and surrogate measures of  insulin sensitivity in obese children and adolescents
PDF) Assessment of disturbed glucose metabolism and surrogate measures of insulin sensitivity in obese children and adolescents

Frontiers | Potential Novel Serum Metabolic Markers Associated With  Progression of Prediabetes to Overt Diabetes in a Chinese Population
Frontiers | Potential Novel Serum Metabolic Markers Associated With Progression of Prediabetes to Overt Diabetes in a Chinese Population

JCI Insight - Human duct cells contribute to β cell compensation in insulin  resistance
JCI Insight - Human duct cells contribute to β cell compensation in insulin resistance

Phosphatidylinositol metabolism of the renal proximal tubule S3 segment is  disturbed in response to diabetes | Scientific Reports
Phosphatidylinositol metabolism of the renal proximal tubule S3 segment is disturbed in response to diabetes | Scientific Reports

LRH-1 agonism favours an immune-islet dialogue which protects against  diabetes mellitus | Nature Communications
LRH-1 agonism favours an immune-islet dialogue which protects against diabetes mellitus | Nature Communications

Molecules | Free Full-Text | Progress in Metabonomics of Type 2 Diabetes  Mellitus
Molecules | Free Full-Text | Progress in Metabonomics of Type 2 Diabetes Mellitus

Circulating miRNA profile at different stages of gestational diabetes.... |  Download Scientific Diagram
Circulating miRNA profile at different stages of gestational diabetes.... | Download Scientific Diagram